The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke
Abstract
T lymphocytes are increasingly recognized as key modulators of detrimental inflammatory cascades in acute ischaemic stroke, but the potential of T cell-targeted therapy in brain ischaemia is largely unexplored. Here, we characterize the effect of inhibiting leukocyte very late antigen-4 and endothelial vascular cell adhesion molecule-1-mediated brain invasion-currently the most effective strategy in primary neuroinflammatory brain disease in murine ischaemic stroke models. Very late antigen-4 blockade by monoclonal antibodies improved outcome in models of moderate stroke lesions by inhibiting cerebral leukocyte invasion and neurotoxic cytokine production without increasing the susceptibility to bacterial infections. Gene silencing of the endothelial very late antigen-4 counterpart vascular cell adhesion molecule-1 by in vivo small interfering RNA injection resulted in an equally potent reduction of infarct volume and post-ischaemic neuroinflammation. Furthermore, very late antigen-4-inhibition effectively reduced the post-ischaemic vascular cell adhesion molecule-1 upregulation, suggesting an additional cross-signalling between invading leukocytes and the cerebral endothelium. Dissecting the specific impact of leukocyte subpopulations showed that invading T cells, via their humoral secretion (interferon-γ) and immediate cytotoxic mechanisms (perforin), were the principal pathways for delayed post-ischaemic tissue injury. Thus, targeting T lymphocyte-migration represents a promising therapeutic approach for ischaemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Donnan, G. A., Fisher, M., Macleod, M., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,218
The inflammatory response in myocardial infarction
Frangogiannis, N. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00434-5 · Cited by 2,011
Elices, M. J., Osborn, L., Takada, Y., Crouse, C., Luhowskyj, S., Hemler, M. E., & Lobb, R. R. (1990) · Cell · doi:10.1016/0092-8674(90)90661-w · Cited by 1,808
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
A Semiautomated Method for Measuring Brain Infarct Volume
Swanson, R. A., Morton, M. T., Tsao-Wu, G., Savalos, R. A., Davidson, C., & Sharp, F. R. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.47 · Cited by 1,644
Functional significance of the perforin/granzyme cell death pathway
Trapani, J. A., & Smyth, M. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri911 · Cited by 1,291
The inflammatory response in stroke
Wang, Q., Tang, X. N., & Yenari, M. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.014 · Cited by 1,177
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
Lymphocyte-Mediated Cytotoxicity
Russell, J. H., & Ley, T. J. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100201.131730 · Cited by 1,122
Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., & Veltkamp, R. (2009) · Nature Medicine · doi:10.1038/nm.1927 · Cited by 1,115
Self-citationTemporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke
Gelderblom, M., Leypoldt, F., Steinbach, K., Behrens, D., Choe, C.-U., Siler, D. A., Arumugam, T. V., Orthey, E., Gerloff, C., Tolosa, E., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.534503 · Cited by 1,066
Central nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. Z. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 930
Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., Iwaki, T., Okada, Y., Iida, M., Cua, D. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1999 · Cited by 842
Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.57 · Cited by 835
Regulatory T cells and mechanisms of immune system control
O'Garra, A., & Vieira, P. (2004) · Nature Medicine · doi:10.1038/nm0804-801 · Cited by 810
The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
Engelhardt, B., & Sorokin, L. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0177-0 · Cited by 778
Role of T Lymphocytes and Interferon-γ in Ischemic Stroke
Yilmaz, G., Arumugam, T. V., Stokes, K. Y., & Granger, D. N. (2006) · Circulation · doi:10.1161/circulationaha.105.593046 · Cited by 722
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Bartholomäus, I., Kawakami, N., Odoardi, F., Schläger, C., Miljkovic, D., Ellwart, J. W., Klinkert, W. E. F., Flügel-Koch, C., Issekutz, T. B., Wekerle, H., et al. (2009) · Nature · doi:10.1038/nature08478 · Cited by 685
Matsuo, Y., Onodera, H., Shiga, Y., Nakamura, M., Ninomiya, M., Kihara, T., & Kogure, K. (1994) · Stroke · doi:10.1161/01.str.25.7.1469 · Cited by 485
Robbins, M., Judge, A., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 449
Acute ischaemic stroke and infection: recent and emerging concepts
Emsley, H. C., & Hopkins, S. J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70061-9 · Cited by 416
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia
Zhang, L., Schallert, T., Zhang, Z. G., Jiang, Q., Arniego, P., Li, Q., Lu, M., & Chopp, M. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(02)00114-0 · Cited by 410
Infection After Acute Ischemic Stroke: A Manifestation of Brain-Induced Immunodepression
Chamorro, A., Urra, X., & Planas, A. M. (2007) · Stroke · doi:10.1161/01.str.0000258346.68966.9d · Cited by 392
Damle, N. K., Klussman, K., Linsley, P. S., & Aruffo, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.1985 · Cited by 387
NK cells at the interface between innate and adaptive immunity
Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G., & Moretta, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402170 · Cited by 387
Integrin activation and structural rearrangement
Takagi, J., & Springer, T. A. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18613.x · Cited by 384
CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.
Zwacka, R. M., Zhang, Y., Halldorson, J., Schlossberg, H., Dudus, L., & Engelhardt, J. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119533 · Cited by 365
Regulatory T cells – a brief history and perspective
Sakaguchi, S., Wing, K., & Miyara, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737593 · Cited by 362
Kleinschnitz, C., Schwab, N., Kraft, P., Hagedorn, I., Dreykluft, A., Schwarz, T., Austinat, M., Nieswandt, B., Wiendl, H., & Stoll, G. (2010) · Blood · doi:10.1182/blood-2009-10-249078 · Cited by 358
Vajkoczy, P., Laschinger, M., & Engelhardt, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12440 · Cited by 357
T- and B-Cell-Deficient Mice with Experimental Stroke have Reduced Lesion Size and Inflammation
Hum, P. D., Subramanian, S., Parker, S. M., Afentoulis, M. E., Kaler, L. J., Vandenbark, A. A., & Offner, H. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600482 · Cited by 355
Bench to Bedside: The Quest for Quality in Experimental Stroke Research
Dirnagl, U. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600298 · Cited by 349
Zipp, F., & Aktas, O. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.006 · Cited by 348
Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab
Steinman, L. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1752 · Cited by 317
Anti-α4 integrin therapy for multiple sclerosis: Mechanisms and rationale
Rice, G. P. A., Hartung, H.-P., & Calabresi, P. A. (2005) · Neurology · doi:10.1212/01.wnl.0000158329.30470.d0 · Cited by 305
Jander, S., Kraemer, M., Schroeter, M., Witte, O. W., & Stoll, G. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.5 · Cited by 297
Active participation of endothelial cells in inflammation
Cook-Mills, J. M., & Deem, T. L. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904554 · Cited by 282
Mechanisms of Transendothelial Migration of Leukocytes
Muller, W. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.200717 · Cited by 282
van Seventer, G. A., Newman, W., Shimizu, Y., Nutman, T. B., Tanaka, Y., Horgan, K. J., Gopal, T. V., Ennis, E., O'Sullivan, D., & Grey, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.901 · Cited by 281
Davies, C. A., Loddick, S. A., Toulmond, S., Stroemer, R. P., Hunt, J., & Rothwell, N. J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199901000-00010 · Cited by 236
Engelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D., & Hoch, G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4271 · Cited by 203
Gene therapy progress and prospects: Hydrodynamic gene delivery
Herweijer, H., & Wolff, J. A. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302891 · Cited by 186
Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines
Engelhardt, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.05.019 · Cited by 180
Antibody to the α4 Integrin Decreases Infarct Size in Transient Focal Cerebral Ischemia in Rats
Becker, K., Kindrick, D., Relton, J., Harlan, J., & Winn, R. (2001) · Stroke · doi:10.1161/01.str.32.1.206 · Cited by 168
Liesz, A., Hagmann, S., Zschoche, C., Adamek, J., Zhou, W., Sun, L., Hug, A., Zorn, M., Dalpke, A., Nawroth, P., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.549618 · Cited by 168
Self-citationNatalizumab: Targeting α4-Integrins in Multiple Sclerosis
Engelhardt, B., & Kappos, L. (2007) · Neurodegenerative Diseases · doi:10.1159/000109933 · Cited by 157
Laschinger, M., & Engelhardt, B. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00156-3 · Cited by 149
Lambertsen, K. L., Meldgaard, M., Ladeby, R., & Finsen, B. R. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600014 · Cited by 145
α4 integrins and the immune response
Rose, D. M., Han, J., & Ginsberg, M. H. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18611.x · Cited by 143
Ibbotson, G., Doig, C., Kaur, J., Gill, V., Ostrovsky, L. L., Fairhead, T., & Kubes, P. (2001) · Nature Medicine · doi:10.1038/86539 · Cited by 137
Inflammation After Stroke: Is It Harmful?
del Zoppo, G. J., Becker, K. J., & Hallenbeck, J. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.4.669 · Cited by 137
Structural impact of hydrodynamic injection on mouse liver
Suda, T., Gao, X., Stolz, D. B., & Liu, D. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302865 · Cited by 137
Anti-VCAM-1 Antibodies did not Protect against Ischemic Damage Either in Rats Or in Mice
Justicia, C., Martín, A., Rojas, S., Gironella, M., Cervera, Á., Panés, J., Chamorro, Á., & Planas, A. M. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600198 · Cited by 117
Endothelial signalling events during leukocyte transmigration
Hordijk, P. L. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05440.x · Cited by 110
Relton, J. K., Sloan, K. E., Frew, E. M., Whalley, E. T., Adams, S. P., & Lobb, R. R. (2001) · Stroke · doi:10.1161/01.str.32.1.199 · Cited by 97
Harris, A. K., Ergul, A., Kozak, A., Machado, L. S., Johnson, M. H., & Fagan, S. C. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-49 · Cited by 85
Systemic siRNA delivery via hydrodynamic intravascular injection
Lewis, D. L., & Wolff, J. A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.002 · Cited by 83
Gee, J. M., Kalil, A., Shea, C., & Becker, K. J. (2007) · Stroke · doi:10.1161/01.str.0000248425.59176.7b · Cited by 76
Inflammation in Stroke: The Good, the Bad, and the Unknown
Dirnagl, U. (2004) · Springer eBooks · doi:10.1007/978-3-662-05426-0_5 · Cited by 61
Chaitanya, G. V., Schwaninger, M., Alexander, J. S., & Babu, P. P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.067 · Cited by 58
Stegemann‐Koniszewski, S., Dahlberg, S., Kröger, A., Gereke, M., Bruder, D., Henriques‐Normark, B., & Gunzer, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004840 · Cited by 42
Self-citationJander, S., Pohl, J., Gillen, C., Schroeter, M., & Stoll, G. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00109-9 · Cited by 38
Lo, E. H. (2009) · Nature Medicine · doi:10.1038/nm0809-844 · Cited by 34
In vivo delivery of small interfering RNA targeting brain capillary endothelial cells
Hino, T., Yokota, T., Ito, S., Nishina, K., Kang, Y., Mori, S., Hori, S., Kanda, T., Terasaki, T., & Mizusawa, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.173 · Cited by 29
Leucocyte depletion does not affect post-ischaemic nerve cell damage in the rat
Sch�rer, L., Gr�gaard, B., Gerdin, B., Kempski, O. S., & Arfors, K. E. (1991) · Acta Neurochirurgica · doi:10.1007/bf01402514 · Cited by 22
Cited by
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640
“This degree of neuroinflammation has been associated with CNS infection (Goldman et al. 2001), stroke (Liesz et al. 2011), or disease (Linker et al. 2002; Walter et al. 2007).”
Chamorro, Á., Dirnagl, U., Urra, X., & Planas, A. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00114-9 · Cited by 1,198
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities
Candelario-Jalil, E., Dijkhuizen, R. M., & Magnus, T. (2022) · Stroke · doi:10.1161/strokeaha.122.036946 · Cited by 953
Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke
Singh, V., Roth, S., Llovera, G., Sadler, R., Garzetti, D., Stecher, B., Dichgans, M., & Liesz, A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1114-16.2016 · Cited by 794
Self-citation
Metadata
- Authors
- Liesz, A., Zhou, W., Mracskó, É., Karcher, S., Bauer, H., Schwarting, S., Sun, L., Bruder, D., Stegemann, S., Cerwenka, A., Sommer, C., Dalpke, A. H., & Veltkamp, R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-22
- Volume
- 134
- Issue
- 3
- Pages
- 704-720
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1988100193
- Cited by
- 411
- References
- 70
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.